Gut microbiota imbalances in Tunisian participants with type 1 and type 2 diabetes mellitus.

Bibliographic Details
Title: Gut microbiota imbalances in Tunisian participants with type 1 and type 2 diabetes mellitus.
Authors: Fassatoui, Meriem, Lopez-Siles, Mireia, Díaz-Rizzolo, Diana A., Jmel, Haifa, Naouali, Chokri, Abdessalem, Ghaith, Chikhaoui, Asma, Nadal, Belén, Jamoussi, Henda, Abid, Abdelmajid, Gomis, Ramon, Abdelhak, Sonia, Martinez-Medina, Margarita, Kefi, Rym
Source: Bioscience Reports; 6/28/2019, Vol. 39 Issue 6, p1-7, 7p
Subject Terms: GUT microbiome, TYPE 2 diabetes, IMMUNE system, POLYMERASE chain reaction, MULTIVARIATE analysis
Abstract: Gut microbiota plays an important role in the regulation of the immune system and host's metabolism. We aimed to characterize the gut microbiota of Tunisian participants with and without diabetes. We enrolled ten participants with type 1 diabetes mellitus (T1DM), ten patients with type 2 diabetes mellitus (T2DM), and 11 subjects without diabetes. Bacteria was quantified in fecal samples by quantitative PCR (qPCR). Statistical tests and multivariate analysis were performed using RStudio program. Results showed that the proportions of Firmicutes, Akkermansia muciniphila, and Faecalibacterium prausnitzii (P=0.041), as well as, the ratio Firmicutes/Bacteroidetes decreased in participants with T1DM compared with those without diabetes (p = 0.036). Participants with T2DM presented a reduction in the amounts of A. muciniphila and F. prausnitzii compared with those without diabetes (P=0.036). Furthermore, A muciniphila is negatively correlated with glucose level (P=0.022) and glycated hemoglobin (HbA1c) (P=0.035).Multivariate analysis revealed that participants with diabetes formed a cluster apart compared with those without diabetes. In conclusion the gut bacteria of Tunisian participants with diabetes was altered. The gut bacterial profile, especially the distribution of A muciniphila in participants with diabetes was affected by glycemic dysregulation. The investigation of the gut microbiota may help clinicians to improve diagnosis and treatment of diabetes and its complications. [ABSTRACT FROM AUTHOR]
Copyright of Bioscience Reports is the property of Portland Press Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:01448463
DOI:10.1042/BSR20182348
Published in:Bioscience Reports
Language:English